PI: 06 CFL Gone Wild - Vyepti Untitled Letter

Jason and Virginia from ‪@complianceforward‬ complete a rapid response review of the recent enforcement letter issued for violative promotion using CFL (consistent with FDA approved labeling) data to promote efficacy claims and also PRO (patient reported outcomes) data from post-hoc analyses. Listen and learn! Like what you hear, subscribe to the Promotional Intelligence podcast to stay up-to-date on all things related to Regulatory Ad Promo in pharma & biotech.